混凝土与无混凝土单部位膝关节关节整形术之间的生存比较:一项病例对照研究,倾向性得分匹配
Pierre-Alban Bouché1, Nicolas Gaujac1, Wilfrid Graff1
1Service de Chirurgie Orthopédique et Traumatologique, Groupe Hospitalier Diaconesses Croix St-Simon, Paris, France.
Orthopaedics & traumatology, surgery & research : OTSR
|July 26, 2024
概括
在单间膝关节关节整形术 (UKA) 中,化和无化部部件的存活率相似. 术前部形被确定为UKA失败的危险因素,突出其在患者选择中的重要性.
科学领域:
- 整形外科手术 整形外科手术
- 生物材料工程 生物材料工程
- 临床结果研究研究
背景情况:
- 早期无水泥假肢的结果令人失望,但进步的目标是提高生存率.
- 单部位膝关节关节整形术 (UKA) 是针对特定膝关节关节炎病例的全膝关节置换的替代方案.
- 在UKA中,脚部部件的固定方法,有或没有,是长期假肢存活的关键因素.
研究的目的:
- 为了比较中间UKA的存活率与固的部件与无的部件.
- 为了调查无水泥的部植入物是否提供优越的存活率相比,在澳大利亚的水泥植入物.
- 为了确定与UKA失败相关的风险因素.
主要方法:
- 一个单一中心的病例控制研究,涉及94个中介性UKA与结的部件.
- 倾向性得分匹配被用来将固的病例与94个介质UKAs配对,其中有无固的部件.
- 根据最后一次随访的全因修复手术评估了生存率,并对失败原因进行了二次分析.
主要成果:
- 平均随访时间为6.1年.
- 五年后的总体存活率是可比的:91.5%的化部件和93.2%的无化部件.
- 在混凝土和无混凝土组之间没有观察到生存率的显著差异 (p=0.6).
- 术前部形被确定为衰竭的重要危险因素 (HR: 1.11).
结论:
- 在中部UKA中,在化和无化部件之间的选择不会显著影响存活率.
- 术前部形是影响UKA成功的关键因素.
- 进一步的研究可能会探索影响UKA寿命的其他因素.
更多相关视频
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
241
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
14.4K
相关概念视频
01:20Comparing the Survival Analysis of Two or More Groups
168
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
168
01:24Kaplan-Meier Approach
117
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
117
01:21Cancer Survival Analysis
336
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
336